Literature DB >> 22700356

Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic study.

Samay Jain1, Thanh G Ton, Subashan Perera, Yan Zheng, Phyllis K Stein, Evan Thacker, Elsa S Strotmeyer, Anne B Newman, Will T Longstreth.   

Abstract

Changes in cardiovascular physiology in Parkinson's disease (PD) are common and may occur prior to diagnostic parkinsonian motor signs. We investigated associations of electrocardiographic (ECG) abnormalities, orthostasis, heart rate variability, and carotid stenosis with the risk of PD diagnosis in the Cardiovascular Health Study, a community-based cohort of older adults. ECG abnormality, orthostasis (symptomatic or asymptomatic), heart rate variability (24-hour Holter monitoring), and any carotid stenosis (≥1%) by ultrasound were modeled as primary predictors of incident PD diagnosis using multivariable logistic regression. Incident PD cases were identified by at least 1 of the following: self-report, antiparkinsonian medication use, and ICD-9. If unadjusted models were significant, they were adjusted or stratified by age, sex, and smoking status, and those in which predictors were still significant (P ≤ .05) were also adjusted for race, diabetes, total cholesterol, low-density lipoprotein, blood pressure, body mass index, physical activity, education level, stroke, and C-reactive protein. Of 5888 participants, 154 incident PD cases were identified over 14 years of follow-up. After adjusting models with all covariates, those with any ECG abnormality (odds ratio [OR], 1.45; 95% CI, 1.02-2.07; P = .04) or any carotid stenosis (OR, 2.40; 95% CI, 1.40-4.09; P = .001) at baseline had a higher risk of incident PD diagnosis. Orthostasis and heart rate variability were not significant predictors. This exploratory study suggests that carotid stenosis and ECG abnormalities occur prior to motor signs in PD, thus serving as potential premotor features or risk factors for PD diagnosis. Replication is needed in a population with more thorough ascertainment of PD onset.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700356      PMCID: PMC3652377          DOI: 10.1002/mds.24979

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

1.  The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression.

Authors:  P M Rautaharju; L P Park; B R Chaitman; F Rautaharju; Z M Zhang
Journal:  J Electrocardiol       Date:  1998-07       Impact factor: 1.438

2.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

3.  Physical activity and the risk of Parkinson disease.

Authors:  H Chen; S M Zhang; M A Schwarzschild; M A Hernán; A Ascherio
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

4.  Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.

Authors:  A Bloch; A Probst; H Bissig; H Adams; M Tolnay
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

5.  Methylenetetrahydrofolate reductase C677T genotype and PD.

Authors:  Lonneke M L de Lau; Peter J Koudstaal; Joyce B J van Meurs; André G Uitterlinden; Albert Hofman; Monique M B Breteler
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

6.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

7.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

8.  Use of a self-report-generated Charlson Comorbidity Index for predicting mortality.

Authors:  Saima Chaudhry; Lei Jin; David Meltzer
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

Review 9.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

Review 10.  Dysautonomia in Parkinson's disease: neurocardiological abnormalities.

Authors:  David S Goldstein
Journal:  Lancet Neurol       Date:  2003-11       Impact factor: 44.182

View more
  14 in total

1.  [ECG changes in primary neurological disorders, systemic diseases and primary cardioymopathies].

Authors:  E Kaya; C Fischer; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-05-09

Review 2.  Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation.

Authors:  Beatrice De Maria; Laura Adelaide Dalla Vecchia; Alberto Porta; Maria Teresa La Rovere
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-08

3.  Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.

Authors:  Samay Jain; Jayandra Himali; Alexa Beiser; Thanh G N Ton; Margaret Kelly-Hayes; Mary Lou Biggs; Joseph A C Delaney; Caterina Rosano; Sudha Seshadri; Samuel A Frank
Journal:  Am J Epidemiol       Date:  2014-12-29       Impact factor: 4.897

4.  Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study.

Authors:  Alvaro Alonso; Xuemei Huang; Thomas H Mosley; Gerardo Heiss; Honglei Chen
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

Review 5.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

6.  Lower Blood Lipid Level Is Associated with the Occurrence of Parkinson's Disease: A Meta-Analysis and Systematic Review.

Authors:  Xue Hong; Wenting Guo; Shanshan Li
Journal:  Int J Clin Pract       Date:  2022-06-09       Impact factor: 3.149

7.  Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease.

Authors:  Walter Maetzler; Marie Karam; Monika Fruhmann Berger; Tanja Heger; Corina Maetzler; Heinz Ruediger; Juliana Bronzova; Patricia Pita Lobo; Joaquim J Ferreira; Tjalf Ziemssen; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2014-07-20       Impact factor: 3.575

Review 8.  Autonomic disorders predicting Parkinson's disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

Review 9.  Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Authors:  Sebastian Heinzel; Benjamin Roeben; Yoav Ben-Shlomo; Stefanie Lerche; Guido Alves; Paolo Barone; Stefanie Behnke; Henk W Berendse; Bastiaan R Bloem; David Burn; Richard Dodel; Donald G Grosset; Michele Hu; Meike Kasten; Rejko Krüger; Marcello Moccia; Brit Mollenhauer; Wolfgang Oertel; Ulrike Suenkel; Uwe Walter; Karin Wirdefeldt; Inga Liepelt-Scarfone; Walter Maetzler; Daniela Berg
Journal:  Front Aging Neurosci       Date:  2016-06-22       Impact factor: 5.750

10.  Patterns of heart rate variability and cardiac autonomic modulations in controlled and uncontrolled asthmatic patients.

Authors:  Mohamed Faisal Lutfi
Journal:  BMC Pulm Med       Date:  2015-10-12       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.